CGEN Compugen Ltd

Price (delayed)

$2.34

Market cap

$221.65M

P/E Ratio

6.32

Dividend/share

N/A

EPS

$0.37

Enterprise value

$139.06M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 99

Compugen is a clinical-stage therapeutic discovery and development company utilizing Unigen™, its AI/ML powered computational discovery platform, to identify novel drug targets and to develop therapeutics in the field of cancer ...

Highlights
Compugen's gross margin has increased by 39% YoY
Compugen's equity has surged by 77% YoY but it has decreased by 7% QoQ
Compugen's quick ratio has increased by 21% YoY but it has decreased by 8% QoQ
The debt has grown by 3.1% from the previous quarter

Key stats

What are the main financial stats of CGEN

CGEN stock price

How has the Compugen stock price performed over time
Intraday
-6.02%
1 week
-2.9%
1 month
-10.52%
1 year
63.64%
YTD
52.94%
QTD
9.35%

Financial performance

How have Compugen's revenue and profit performed over time
Revenue
$74M
Gross profit
$64.3M
Operating income
$30.3M
Net income
$35.19M
Gross margin
86.9%
Net margin
47.6%
The net margin has soared by 154% YoY
Compugen's operating margin has soared by 146% YoY but it has decreased by 3.3% from the previous quarter
Compugen's gross margin has increased by 39% YoY

Price vs fundamentals

How does CGEN's price correlate with its fundamentals

Growth

What is Compugen's growth rate over time

Valuation

What is Compugen stock price valuation
P/E
6.32
P/B
2.49
P/S
2.99
EV/EBIT
3.95
EV/EBITDA
3.9
EV/Sales
1.88
Compugen's equity has surged by 77% YoY but it has decreased by 7% QoQ
The stock's price to book (P/B) is 20% more than its last 4 quarters average of 2.2 and 15% more than its 5-year quarterly average of 2.3
CGEN's P/S is 80% below its 5-year quarterly average of 15.7 and 53% below its last 4 quarters average of 6.8

Efficiency

How efficient is Compugen business performance
Compugen's return on sales has surged by 171% YoY
Compugen's ROE has decreased by 11% from the previous quarter
CGEN's ROIC is down by 9% QoQ
CGEN's return on assets is down by 5% since the previous quarter

Dividends

What is CGEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CGEN.

Financial health

How did Compugen financials performed over time
CGEN's total assets is 179% greater than its total liabilities
CGEN's total assets is up by 30% year-on-year but it is down by 5% since the previous quarter
The current ratio has grown by 21% YoY but it has contracted by 8% from the previous quarter
The debt is 97% less than the equity
Compugen's equity has surged by 77% YoY but it has decreased by 7% QoQ
The debt to equity has shrunk by 50% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.